Table 1.
Clinical characteristics
| Quantity n | Male, % | Age (years)* | Renal insufficiency, % | Diabetes mellitus, % | Dyslipidemia % | Hypertension % | Smoker % | CLI % | Lesion length (mm)* | Occlusion % | Target vessel, % | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | PT | TT | PA | |||||||||||||
| Rand et al. 2006 | BA | 27 | N/A | 72.0 (47–80) | 11.0 | 70.0 | N/A | N/A | 63.0 | 70.4 | 24.0 (5–30) | 14.8 | N/A | N/A | N/A | N/A |
| NDMS | 24 | N/A | 68.3 (53–85) | 21.0 | 67.0 | N/A | N/A | 58.0 | 83.3 | 17.4±3.2 | 8.3 | N/A | N/A | N/A | N/A | |
| Follow-up | 6 months | |||||||||||||||
|
| ||||||||||||||||
| Falkowski et al. 2009 | DES | 25 | 56.0 | 70.5 (55–86) | N/A | 40.0 | 32.0 | 64.0 | 48.0 | 36.0 | 18.2±3.5 | N/A | 28.0 | 12.0 | 32.0 | 28.0 |
| NDMS | 25 | 60.0 | 72±10 | N/A | 40.0 | 40.0 | 60.0 | 40.0 | 28.0 | N/A | N/A | 24.0 | 8.0 | 36.0 | 32.0 | |
| Follow-up | 6 months | |||||||||||||||
|
| ||||||||||||||||
| Randon et al. 2010 | BA | 22 | 63.6 | 72±9 | 36.4 | 54.5 | 40.9 | 100.0 | 18.2 | 100.0 | N/A | N/A | 28.1 | 21.9 | 28.1 | 21.9 |
| NDMS | 16 | 37.5 | 12.5 | 62.5 | 43.7 | 100.0 | 6.2 | 100.0 | N/A | 29.2 | 25.0 | 16.6 | 29.2 | |||
| Follow-up | 12 months | |||||||||||||||
|
| ||||||||||||||||
| Brodmann et al. 2011 | BA | 33 | 39.4 | 74.9±1.3 | N/A | 72.7 | 18.2 | 81.8 | 24.2 | N/A | 78.5 (60.0–96.9) | 30.3 | N/A | N/A | N/A | N/A |
| NDMS | 21 | 57.1 | 68.9±2.9 | N/A | 76.2 | 66.7 | 90.5 | 33.3 | N/A | 27.9 (21.6–31.1) | 30.0 | N/A | N/A | N/A | N/A | |
| Follow-up | 12 months | |||||||||||||||
|
| ||||||||||||||||
| Rastan et al. 2011 | DES | 82 | 67.9 | 73.4±8 | 35.8 | 56.8 | 76.5 | 91.4 | 28.4 | 51.2 | 30.0±8.0 | 23.2 | 22 | 17 | 42 | 19 |
| NDMS | 79 | 64.9 | 72.3±9 | 35.1 | 50.6 | 76.6 | 88.3 | 28.6 | 41.8 | 31.0±9.0 | 21.5 | 31 | 13 | 33 | 23 | |
| Follow-up | 12 months | |||||||||||||||
|
| ||||||||||||||||
| Rand et al. 2011 | BA | 44 | 62.2 | 72.1±9.5 | N/A | 75.6 | N/A | N/A | N/A | N/A | 20.7±20.1 | 27.5 | N/A | N/A | N/A | N/A |
| NDMS | 44 | 68.2 | 71.4±8.0 | N/A | 79.5 | N/A | N/A | N/A | N/A | 21.1±12.2 | 19.4 | N/A | N/A | N/A | N/A | |
| Follow-up | 9 months | |||||||||||||||
|
| ||||||||||||||||
| Bosiers et al. 2012 | DES | 74 | 61.0 | 75.0±8.0 | 30.0 | 60.0 | 38.0 | 64.0 | 16.0 | 100 | 15.9±10.2 | 15.0 | 37.0 | 12.0 | 28.0 | 23.0 |
| NDMS | 66 | 67.0 | 76.0±8.4 | 33.0 | 50.0 | 38.0 | 74.0 | 11.0 | 100 | 18.9±10.0 | 17.0 | 29.0 | 13.0 | 30.0 | 28.0 | |
| Follow-up | 12 months | |||||||||||||||
|
| ||||||||||||||||
| Scheinert et al. 2012 | DES | 99 | 67.7 | 72.4±9.4 | N/A | 64.6 | 77.6 | 89.9 | 38.4 | N/A | 26.9±20.9 | 81.3 | N/A | N/A | N/A | N/A |
| BA | 101 | 75.2 | 74.3±8.2 | N/A | 64.4 | 68.3 | 91.1 | 26.3 | N/A | 26.8±21.3 | 75.4 | N/A | N/A | N/A | N/A | |
| Follow-up | 12 months | |||||||||||||||
|
| ||||||||||||||||
| Liistro et al. 2013 | DEB | 65 | 83.1 | 74.0±9.4 | 10.8 | 100 | 35.4 | 70.8 | 20.0 | 100 | 129±83 | 77.5 | 46.3 | 16.3 | 20.0 | 17.5 |
| BA | 67 | 77.6 | 75.0±9.6 | 10.4 | 100 | 23.9 | 77.6 | 10.4 | 100 | 131±79 | 82.1 | 41.0 | 23.1 | 9.0 | 26.9 | |
| Follow-up | 12 months | |||||||||||||||
|
| ||||||||||||||||
| Siablis et al. 2014 | DEB | 25 | 80.0 | 67.6±11.3 | 44.0 | 76.0 | 40.0 | 56.0 | 36.0 | N/A | 148.0±56.7 | 12.0 | 52.0 | 24.0 | N/A | 24.0 |
| DES | 25 | 72.0 | 75.3±8.0 | 32.0 | 64.0 | 52.0 | 44.0 | 24.0 | 100 | 127.0±46.5 | 23.0 | 50.0 | 27.0 | N/A | 23.0 | |
| Follow-up | 6 months | |||||||||||||||
|
| ||||||||||||||||
| Zeller et al. 2014 | DEB | 239 | 76.2 | 73.3±8.2 | 8.6 | 75.7 | 73.2 | 89.5 | 15.1 | 100.0 | 101.5±91.0 | 38.6 | N/A | N/A | N/A | N/A |
| BA | 119 | 70.6 | 71.7±9.9 | 12.5 | 68.9 | 67.2 | 89.1 | 13.4 | 99.0 | 128.6±94.6 | 45.9 | N/A | N/A | N/A | N/A | |
| Follow-up | 12 months | |||||||||||||||
RCT, randomized controlled trial; BA, balloon angioplasty; NDMS, nondrug metal stent; DES, drug-eluting stent; DEB, drug-eluting balloon; N/A, not available; CLI, critical limb ischemia; AT, anterior tibial artery; PT, posterior tibial artery; TT, tibioperoneal trunk; PA, peroneal artery.
*
Data are presented as mean±standard deviation or median (range).